miR-412抑制SOX6对黑色素瘤细胞的增殖及侵袭力影响的研究

doi:10.3969/j.issn.1000-8535.2024.06.006

摘要/Abstract

摘要： 目的检测微小RNA（miR）在人黑色素瘤中的表达情况,研究miR-412通过抑制性别确定区Y框转录因子6（SOX6）的表达影响黑色素瘤细胞增殖及侵袭能力的变化。方法癌症基因组图谱（TCGA）数据库分析发现miR-412在黑色素瘤中异常表达,为研究其表达与肿瘤的相关性,采用Transwell小室,非锚定独立生长实验分析miR-412对黑色素瘤细胞增殖及侵袭能力的影响。软件预测SOX6可能为其靶向基因,采用荧光素酶报告分析及Western blot实验检测SOX6与miR-412的靶向调节情况。结果 TCGA数据库分析黑色素瘤组织中miR-412表达水平高于正常对照组,表达越高,生存时间越短。Transwell小室,非锚定独立生长实验显示miR-412过表达后促进细胞增殖及侵袭能力,而下调miR-412后抑制黑色素瘤细胞增殖及侵袭能力;通过靶点预测miR-412结合SOX6基因3’-非翻译区（UTR）,导致SOX6蛋白因miR-412表达增高而下调;同时在miR-412下调的细胞中抑制SOX6表达可恢复黑色素瘤细胞的增殖及侵袭能力。结论 miR-412过表达后促进黑色素瘤细胞增殖及侵袭能力,反之则抑制黑色素瘤细胞增殖及侵袭能力。 miR-412通过靶向调控SOX6影响黑色素瘤细胞增殖及侵袭,提示miR-412在黑色素瘤的发病过程中起重要作用,是潜在的治疗靶点。

关键词: miR-412, SOX6, 黑色素瘤, 增殖, 侵袭

Abstract: Objective To assess the expression of miR-412 in human melanoma and investigate how miR-412 modulates melanoma cell proliferation and invasive capacity by inhibiting SRY-Box Transcription Factor 6,（SOX6） expression．Methods Analysis of the TCGA（The Cancer Genome Atlas）database identified aberrant miR-412 expression in melanoma．To explore its relevance to tumorigenesis,we conducted Transwell chamber and non-adherent independent growth assays to examine the effects of miR-412 on melanoma cell proliferation and invasion．Software predictions highlighted SOX6 as a potential target gene．We performed luciferase reporter assays and Western blot experiments to elucidate the regulatory interactions between SOX6 and miR-412．Results TCGA database analysis revealed significantly elevated miR-412 expression levels in melanoma tissues compared to the normal control group．Moreover,higher miR-412 expression correlated with shorter survival times．Functional assays using Transwell chambers and non-adherent independent growth assays demonstrated that overexpressing miR-412 enhanced cell proliferation and invasive capabilities．Conversely,reducing miR-412 expression restrained these attributes in melanoma cells． Target prediction analysis indicated that miR-412 binds to the 3’-UTR region of SOX6,resulting in decreased SOX6 protein levels due to increased miR-412 expression．Intriguingly,inhibiting SOX6 expression concurrently amplified the proliferation and invasive potential of melanoma cells,which was initially dampened by miR-412 downregulation．Conclusions Elevated miR-412 expression augments melanoma cell proliferation and invasive capabilities,while its suppression diminishes these traits．Through its targeted regulation of SOX6,miR-412 exerts a significant influence on melanoma cell proliferation and invasion．These findings underscore the pivotal role of miR-412 in melanoma pathogenesis and underscore its potential as a promising therapeutic target．

Key words: miR-412, SOX6, melanoma, proliferation, invasion

高亚平, 罗于蓝, 谭灵, 赵鹏越, 邱海江. miR-412抑制SOX6对黑色素瘤细胞的增殖及侵袭力影响的研究[J]. 广州医药, 2024, 55(6): 611-617.

GAO Yaping, LUO Yulan, TAN Ling, ZHAO Pengyue, QIU Haijiang. Upregulation of miR-412 promotes melanoma proliferation and invasion by suppressing SOX6 expression[J]. Guangzhou Medical Journal, 2024, 55(6): 611-617.

参考文献

[1] TÍMÁR J,LADÁNYI A.Molecular pathology of skin melanoma:Epidemiology,differential diagnostics,prognosis and therapy prediction[J].Int J Mol Sci,2022,23(10):5384.
[2] ZHANG S,XIE R,ZHONG A,et al.Targeted therapeutic strategies for melanoma[J].Chin Med J(Engl),2023,136(24):2923-2930.
[3] THYAGARAJAN A,SHABAN A,SAHU R P.MicroRNA-directed cancer therapies:Implications in melanoma intervention[J].J Pharmacol Exp Ther,2018,364(1):1-12.
[4] MADHUNAPANTULA S V,ROBERTSON G P.Chemoprevention of melanoma[J].Adv Pharmacol,2012(65):361-398.
[5] CARUSO J P,INBAR O C,BILSKY M H,et al.Stereotactic radiosurgery and immunotherapy for metastatic spinal melanoma[J].Neurosurg Focus,2015,38(3):E6.
[6] ROMERO CORDOBA S L,GUADARRAMA I S,DORANTES M R,et al.miRNA biogenesis:Biological impact in the development of cancer[J].Cancer Biol Ther,2014,15(11):1444-1455.
[7] HAYES J,PERUZZI P P,LAWLER S.MicroRNAs in cancer:Biomarkers,functions and therapy[J].Trends Mol Med,2014,20(8):460-469.
[8] COSTA P M,PEDROSO de LIMA M C.MicroRNAs as molecular targets for cancer therapy:On the modulation of microRNA expression[J].Pharmaceuticals,2013,6(10):1195-1220.
[9] RU N,ZHANG F,LIANG J,et al.MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt[J].Gene,2018(645):163-169.
[10] HUANG C,LUO H.miR-19-5p enhances tumorigenesis in human colorectal cancer cells by targeting TSPYL5[J].DNA Cell Biol,2018,37(1):23-30.
[11] ZHANG G,AI D,YANG X,et al.MicroRNA-610 inhibits tumor growth of melanoma by targeting LRP6[J].Oncotarget,2017,8(57):97361-97370.
[12] 陈晓云,杨伟敏,邓小茜,等.葡萄膜恶性黑色素瘤转移相关的非编码RNA表达谱及竞争性内源RNA调控网络分析[J].眼科学报,2022,37(1):25-35.
[13] BLUM E S,YANG J,KOMATSUBARA K M,et al.Clinical management of uveal and conjunctival melanoma[J].Oncology,2016,30(1):29-32,34-43,48.
[14] ROMERO-CORDOBA S L,SALIDO-GUADARRAMA I,RODRIGUEZ-DORANTES M,et al.miRNA biogenesis:Biological impact in the development of cancer[J].Cancer Biol Ther,2014,15(11):1444-1455.
[15] REDDY K B.MicroRNA(miRNA)in cancer[J].Cancer Cell Int,2015,15(1):38.
[16] LONG J,MENGGEN Q,WUREN Q,et al.MiR-219-5p inhibits the growth and metastasis of malignant melanoma by targeting BCL-2[J].Biomed Res Int,2017(2017):9032502.
[17] BU P,LUO C,HE Q,et al.MicroRNA-9 inhibits the proliferation and migration of malignant melanoma cells via targeting sirituin 1[J].Exp Ther Med,2017,14(2):931-938.
[18] FANG W,FAN Y,FA Z,et al.MicroRNA-625 inhibits tumorigenicity by suppressing proliferation,migration and invasion in malignant melanoma[J].Oncotarget,2017,8(8):1325313263.
[19] WU J,LI J,REN J,et al.MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7[J].Biomed Pharmacother,2017(90):303-310.
[20] OHTSUKA M,LING H,DOKI Y,et al.MicroRNA processing and human cancer[J].J Clin Med,2015,4(8):1651-1667.
[21] SHEN F,CAI W S,FENG Z,et al.MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression[J].Tumour Biol,2015,36(3):1913-1921.
[22] POLIOUDAKIS D,ABELL N S,IYER V R.MiR-503 represses human cell proliferation and directly targets the oncogene DDHD2 by non-canonical target pairing[J].BMC Genomics,2015,16(1):40.
[23] YANG Y,LIU L,ZHANG Y,et al.MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer[J].Int J Cancer,2014 135(7):1531-1542.
[24] 翁沛华. 超声-微泡介导miR-128通过调节PTEN抑制乳腺癌细胞阿霉素耐药[J].广州医药,2021,52(6):35-38.
[25] SONG L,LIN C,GONG H,et al.miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops[J].Cell Res,2013,23(2):274-289.
[26] HO K C,ZHOU Z,SHE Y M,et al.Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability[corrected][J].Proc Natl Acad Sci USA,2011,108(12):4870-4875.
[27] SALAH Z,MELINO G,AQEILAN R I.Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity[J].Cancer Res,2011,71(5):2010-2020.
[28] SHENG Y,YANG Z,FENG Z,et al.MicroRNA-499-5p promotes vascular smooth muscle cell proliferation and migration via inhibiting SOX6[J].Physiol Genomics,2023,55(2):67-74.
[29] ZENG H,CHEN Y X.MiR-19b-3p inhibits hypoxia-ischemia encephalopathy by inhibiting SOX6 expression via activating Wnt/β-catenin pathway[J].Neurochem Res,2023,48(3):874-884.
[30] YANG Z,REN Z,SHE R,et al.MiR-23a-3p regulated by LncRNA SNHG5 suppresses the chondrogenic differentiation of human adipose-derived stem cells via targeting SOX6/SOX5[J].Cell Tissue Res,2021,383(2):723-733.